Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Accounts Payables (2020 - 2022)

Atea Pharmaceuticals has reported Accounts Payables over the past 3 years, most recently at $1.1 million for Q3 2022.

  • Quarterly results put Accounts Payables at $1.1 million for Q3 2022, down 94.96% from a year ago — trailing twelve months through Sep 2022 was $1.1 million (down 94.96% YoY), and the annual figure for FY2021 was $4.5 million, up 7456.67%.
  • Accounts Payables for Q3 2022 was $1.1 million at Atea Pharmaceuticals, down from $13.9 million in the prior quarter.
  • Over the last five years, Accounts Payables for AVIR hit a ceiling of $22.2 million in Q3 2021 and a floor of $60000.0 in Q4 2020.
  • Median Accounts Payables over the past 3 years was $4.5 million (2020), compared with a mean of $7.2 million.
  • Biggest five-year swings in Accounts Payables: skyrocketed 7456.67% in 2021 and later plummeted 94.96% in 2022.
  • Atea Pharmaceuticals' Accounts Payables stood at $60000.0 in 2020, then skyrocketed by 7456.67% to $4.5 million in 2021, then plummeted by 75.34% to $1.1 million in 2022.
  • The last three reported values for Accounts Payables were $1.1 million (Q3 2022), $13.9 million (Q2 2022), and $3.7 million (Q1 2022) per Business Quant data.